Room 221
Sponsored by Bristol Myers Squibb and Johnson & Johnson Alliance

Saturday, March 28

10:45 – 11:45 a.m.
4320. Exploring the Potential of Factor XI Pathway Inhibition in Thromboembolic Diseases
This scientific program will examine the persisting unmet need in ischemic stroke prevention, review the current therapeutic landscape and its limitations, and introduce the scientific rationale for Factor XI inhibition. The session will focus on the ongoing burden of ischemic stroke, the challenges of balancing efficacy and bleeding risk, and emerging evidence that may support potential for a more favorable benefit-risk profile.

Speakers:

Annabelle Santos Volgman, MD, FACC, FAHA

Luciano A. Sposato, MD, MBA, FRCPC

2:45 – 3:45 p.m.
4323. Exploring the Potential of Factor XI Pathway Inhibition in Thromboembolic Diseases
This scientific program will examine the persisting unmet need in ischemic stroke prevention, review the current therapeutic landscape and its limitations, and introduce the scientific rationale for Factor XI inhibition. The session will focus on the ongoing burden of ischemic stroke, the challenges of balancing efficacy and bleeding risk, and emerging evidence that may support potential for a more favorable benefit-risk profile.

Speaker:

Luciano A. Sposato, MD, MBA, FRCPC

Sunday, March 29

9:45 – 10:45 a.m.
4321. Exploring the Potential of Factor XI Pathway Inhibition in Thromboembolic Diseases
This scientific program will examine the persisting unmet need in ischemic stroke prevention, review the current therapeutic landscape and its limitations, and introduce the scientific rationale for Factor XI inhibition. The session will focus on the ongoing burden of ischemic stroke, the challenges of balancing efficacy and bleeding risk, and emerging evidence that may support potential for a more favorable benefit-risk profile.

3 – 4 p.m.
4324. Exploring the Potential of Factor XI Pathway Inhibition in Thromboembolic Diseases
This scientific program will examine the persisting unmet need in ischemic stroke prevention, review the current therapeutic landscape and its limitations, and introduce the scientific rationale for Factor XI inhibition. The session will focus on the ongoing burden of ischemic stroke, the challenges of balancing efficacy and bleeding risk, and emerging evidence that may support potential for a more favorable benefit-risk profile.

Speakers:

Annabelle Santos Volgman, MD, FACC, FAHA

Luciano A. Sposato, MD, MBA, FRCPC

Room 222
Sponsored by GE Healthcare

Saturday, March 28

10 – 10:30 a.m.
4301. Clinical Considerations for Cardiovascular Imaging in Women: The Critical Role of PET
Cardiovascular disease remains the leading cause of morbidity and mortality in women, yet it is frequently underdiagnosed due to sex-specific differences in disease presentation and pathophysiology. Traditional imaging modalities may be limited in women because of smaller coronary vessel size, higher prevalence of non-obstructive coronary artery disease, microvascular dysfunction, and confounding factors such as breast attenuation and hormonal influences.

Positron Emission Tomography (PET) offers unique advantages in the evaluation of cardiovascular disease in women, including superior spatial resolution, routine attenuation correction, and the ability to quantify absolute myocardial blood flow and coronary flow reserve. These capabilities enable more accurate detection of ischemia, identification of coronary microvascular dysfunction, and improved risk stratification—areas where conventional imaging often falls short. Incorporating PET into clinical decision-making allows for a more personalized and precise assessment of cardiovascular risk in women, ultimately supporting earlier diagnosis, targeted therapy, and improved outcomes.

Speaker:

Rupa M. Sanghani, MD
Rush

11 – 11:30 a.m.
4302. Cardiac PET Clarity: Applying the Latest Recommendations to Patient Selection
Gain confidence in selecting the right patients for cardiac PET by diving into the most up-to-date society guidelines and appropriate-use criteria. This interactive learning lab will review key recommendations from leading organizations, outline clinical scenarios where PET delivers unique value, and provide practical decision-making tools to help you apply evidence-based criteria in real-world practice. Through case examples and discussion, you'll learn how to optimize patient care by aligning the right test with the right patient at the right time.

Speaker:

Marcelo Fernando DiCarli, MD
B&W

Noon – 12:30 p.m.
4303. Uncovering Hidden Disease: Flyrcado Case Review Lab
Step inside the Flyrcado Case Review Lab and explore real-world patient cases that reveal the true power of cardiac PET. See how advanced imaging with Flyrcado™ uncovered disease that other modalities missed, and how these insights changed care decisions and improved outcomes. This interactive learning experience will highlight the clinical value of cardiac PET, demonstrate its impact on referral pathways, and give you practical takeaways for applying these insights in your practice.

Speakers:

Mouaz H. Al-Mallah, MD
Houston Methodist

Mahmoud Al Rifai, MD
Houston Methodist

3 – 3:30 p.m.
4305. Implementing Shared Cardiac PET Services: Operational Considerations
This session explores the practical steps for launching and managing shared cardiac PET services across multiple sites or departments. Learn how to design workflows that optimize efficiency, coordinate between cardiology and nuclear medicine teams, and ensure smooth scheduling and patient throughput. Real-world examples will highlight strategies for overcoming common operational challenges.

Speaker:

Jaime Warren, EdD, MBA, BHS, CNMT, NCT
MedAxiom

3:30 – 4 p.m.
4306. Implementing Shared Cardiac PET Services: Technical Considerations
Dive into the technical aspects of shared cardiac PET implementation, including equipment requirements, tracer logistics, image acquisition protocols, and quality assurance standards. This session will address how to maintain consistency across sites, leverage technology for scalability, and ensure compliance with accreditation guidelines.

Speaker:

Jaime Warren, EdD, MBA, BHS, CNMT, NCT
MedAxiom

4 – 4:30 p.m.
4307. Implementing Shared Cardiac PET Services: Building a Sustainable Business Case
Understand the financial framework for shared cardiac PET services, from cost modeling and budgeting to reimbursement models. This session will provide insights into building a sustainable business case, understanding and addressing payor requirements, and identifying opportunities for efficiencies and cost-sharing.

Speaker:

Nicole Knight, LPN, CPC, CCS-P
MedAxiom

Sunday, March 29

9:30 – 10 a.m.
4308. Implementing Shared Cardiac PET Services: Operational Considerations
This session explores the practical steps for launching and managing shared cardiac PET services across multiple sites or departments. Learn how to design workflows that optimize efficiency, coordinate between cardiology and nuclear medicine teams, and ensure smooth scheduling and patient throughput. Real-world examples will highlight strategies for overcoming common operational challenges.

Speaker:

Jaime Warren, EdD, MBA, BHS, CNMT, NCT
MedAxiom

10 – 10:30 a.m.
4309. Implementing Shared Cardiac PET Services: Technical Considerations
Dive into the technical aspects of shared cardiac PET implementation, including equipment requirements, tracer logistics, image acquisition protocols, and quality assurance standards. This session will address how to maintain consistency across sites, leverage technology for scalability, and ensure compliance with accreditation guidelines.

Speaker:

Jaime Warren, EdD, MBA, BHS, CNMT, NCT
MedAxiom

10:30 – 11 a.m.
4310. Implementing Shared Cardiac PET Services: Building a Sustainable Business Case
Understand the financial framework for shared cardiac PET services, from cost modeling and budgeting to reimbursement models. This session will provide insights into building a sustainable business case, understanding and addressing payor requirements, and identifying opportunities for efficiencies and cost-sharing.

Speaker:

Nicole Knight, LPN, CPC, CCS-P
MedAxiom

11:30 a.m. – Noon
4311. Uncovering Hidden Disease: Flyrcado Case Review Lab
Step inside the Flyrcado Case Review Lab and explore real-world patient cases that reveal the true power of cardiac PET. See how advanced imaging with Flyrcado™ uncovered disease that other modalities missed, and how these insights changed care decisions and improved outcomes. This interactive learning experience will highlight the clinical value of cardiac PET, demonstrate its impact on referral pathways, and give you practical takeaways for applying these insights in your practice.

Speakers:

Mouaz H. Al-Mallah, MD
Houston Methodist

Mahmoud Al Rifai, MD
Houston Methodist

12:30 – 1 p.m.
4312. Clinical Considerations For Cardiovascular Imaging in Women: The Critical Role of PET
Cardiovascular disease remains the leading cause of morbidity and mortality in women, yet it is frequently underdiagnosed due to sex-specific differences in disease presentation and pathophysiology. Traditional imaging modalities may be limited in women because of smaller coronary vessel size, higher prevalence of non-obstructive coronary artery disease, microvascular dysfunction, and confounding factors such as breast attenuation and hormonal influences.

Positron Emission Tomography (PET) offers unique advantages in the evaluation of cardiovascular disease in women, including superior spatial resolution, routine attenuation correction, and the ability to quantify absolute myocardial blood flow and coronary flow reserve. These capabilities enable more accurate detection of ischemia, identification of coronary microvascular dysfunction, and improved risk stratification—areas where conventional imaging often falls short. Incorporating PET into clinical decision-making allows for a more personalized and precise assessment of cardiovascular risk in women, ultimately supporting earlier diagnosis, targeted therapy, and improved outcomes.

Speaker:

Rupa M. Sanghani, MD
Rush

1:30 – 2 p.m.
4313. Uncovering Hidden Disease: Flyrcado Case Review Lab
Step inside the Flyrcado Case Review Lab and explore real-world patient cases that reveal the true power of cardiac PET. See how advanced imaging with Flyrcado™ uncovered disease that other modalities missed, and how these insights changed care decisions and improved outcomes. This interactive learning experience will highlight the clinical value of cardiac PET, demonstrate its impact on referral pathways, and give you practical takeaways for applying these insights in your practice.

Speaker:

Jamie Bourque, MD
UVA

2:30 – 3 p.m.
4314. Cardiac PET Clarity: Applying the Latest Recommendations to Patient Selection
Gain confidence in selecting the right patients for cardiac PET by diving into the most up-to-date society guidelines and appropriate-use criteria. This interactive learning lab will review key recommendations from leading organizations, outline clinical scenarios where PET delivers unique value, and provide practical decision-making tools to help you apply evidence-based criteria in real-world practice. Through case examples and discussion, you'll learn how to optimize patient care by aligning the right test with the right patient at the right time.

Speaker:

Marcelo Fernando DiCarli, MD
B&W

3:30 – 4 p.m.
4315. AI in ECG: Clinical Impact and Workflow

Speaker:

Abhishek J. Deshmukh, MBBS
Mayo Clinic

4:30 – 5 p.m.
4316. Trustworthy AI-ECG: Overcoming limitations of the Black Box
Current state of AI-ECG, limitations and challenges for translation to clinical practice, and a vision for transparent and trustworthy AI-ECG.

Speaker:

Manolis Kargiantoulakis, Ph.D.
GE HealthCare

Monday, March 30

9 – 9:30 a.m.
4317. Cardiac PET Clarity: Applying the Latest Recommendations to Patient Selection
Gain confidence in selecting the right patients for cardiac PET by diving into the most up-to-date society guidelines and appropriate-use criteria. This interactive learning lab will review key recommendations from leading organizations, outline clinical scenarios where PET delivers unique value, and provide practical decision-making tools to help you apply evidence-based criteria in real-world practice. Through case examples and discussion, you'll learn how to optimize patient care by aligning the right test with the right patient at the right time.

Speaker:

Marcelo Fernando DiCarli, MD
B&W

10 – 10:30 a.m.
4318. Uncovering Hidden Disease: Flyrcado Case Review Lab
Step inside the Flyrcado Case Review Lab and explore real-world patient cases that reveal the true power of cardiac PET. See how advanced imaging with Flyrcado™ uncovered disease that other modalities missed, and how these insights changed care decisions and improved outcomes. This interactive learning experience will highlight the clinical value of cardiac PET, demonstrate its impact on referral pathways, and give you practical takeaways for applying these insights in your practice.

Speaker:

Jamie Bourque, MD
UVA

Room 225
Sponsored by GE Healthcare

Saturday, March 28

9:30 – 10:30 a.m.
4360. Pioneering Advancements in Echocardiography
Be introduced to the latest development in echo at GE HealthCare the Vivid Pioneer

• Advancements in 2D and 4D imaging in adult and eeds, TTE and TEE
• Innovations in color flow and doppler imaging
• Experience how artificial intelligence can help your day to day
• Latest developments in 4D rendering and quantification
• 30-minute intro to machine followed by hands-on the technologies on EchoPac

Speaker:
Jacob Dewees RDCS
Clinical Luminary Leader
GE HealthCare, CVUS

11 a.m. – Noon
4363. Intro to Strain Imaging: Bringing AFI Into Your Echo Lab
30-minute lecture followed by 30 minutes hands-on

• Introduction to Strain measurement and its importance
• Discover how artificial intelligence has improved Strain Analysis
• Review case studies from real patients
• Understand proper measurement techniques, editing and common pitfalls.
• Understanding Myocardial Strain results both regionally and globally

Speaker:
Christos Mihos, DO
Director, Echocardiography & Non-Invasive Cardiovascular Laboratory, Division of Cardiology
Mount Sinai Medical Center
Miami, FL

1 – 2 p.m.
4364. AFI Strain Imaging in Cardio-Oncology
30-minute lecture followed by 30 minutes hands-on.

• Learn to interpret changes in GLS values to risk-stratify patients receiving cardiotoxic therapies
• Discover how artificial intelligence creates consistency in Strain Analysis
• Review Strain case studies of patients with cardiac toxicity
• Understand proper measurement techniques
• Understanding Myocardial Strain results

Speaker:
Christos Mihos, DO
Director, Echocardiography & Non-Invasive Cardiovascular Laboratory, Division of Cardiology
Mount Sinai Medical Center
Miami, FL

2:30 – 3:30 p.m.
4365. AFI Strain in Hypertrophic Cardiomyopathies

• Understand the role and diagnostic utility of Strain Imaging hypertrophic cardiomyopathy
• The differences in Strain measurements of HCM and hypertensive heart
• Get hands-on learning using EchoPac on real cases

Speaker:
Christos Mihos, DO
Director, Echocardiography & Non-Invasive Cardiovascular Laboratory, Division of Cardiology
Mount Sinai Medical Center
Miami, FL

4 – 4:45 p.m.
4366. 4D Valves: Cropping and Multiplanar Reconstruction of 4D TEE

• Learn how to manipulate 4D TEE echo images
• Review valve orientations needed for Structural Valve procedures and surrounding anatomical landmarks on 4D TEE
• Discover the methods of Multi-Planar Reconstruction (Flexi-Slice)
• Learn how MPRs Flexi-Slice can help with procedural guidance and measurements
• Practice manipulating 4D images from real cases

Sunday, March 29

9:30 – 10:30 a.m.
4361. Intro to Strain Imaging: Bringing AFI Into Your Echo Lab
30-minute lecture followed by 30 minutes hands-on

• Introduction to Strain measurement and its importance
• Discover how artificial intelligence has improved Strain Analysis
• Review case studies from real patients
• Understand proper measurement techniques, editing and common pitfalls.
• Understanding Myocardial Strain results both regionally and globally

Speaker:
Christos Mihos, DO
Director, Echocardiography & Non-Invasive Cardiovascular Laboratory, Division of Cardiology
Mount Sinai Medical Center
Miami, FL

11 a.m. – Noon
4367. AFI Strain in Amyloid and Cardiomyopathies

• Understand the role and diagnostic utility of Strain in imaging cardiomyopathies
• Impact of amyloid on heart muscle and AFI results.
• Strain patterns in various cardiomyopathies and how to differentiate between constrictive and restrictive cardiomyopathies
• Review case studies of different cardiomyopathies on Echo Pac

Speaker:
Christos Mihos, DO
Director, Echocardiography & Non-Invasive Cardiovascular Laboratory, Division of Cardiology
Mount Sinai Medical Center
Miami, FL

1 – 2 p.m.
4368. Artificial Intelligence in Echo: Using AI and Vivid Technologies to Improve Echo Lab Workflow

• Understand the types of artificially intelligent tools that are available in echo
  • View recognition
  • Measurements – Cardiac Auto Doppler, Easy AFI, Auto EF
  • Image Acquisition Guidance with Caption
  • Offline analysis and reporting with Echo Pilot on View Point
• Discover other technologies that can help make your Echo Lab more efficient
• Review images on EchoPAC and how to apply AI

Speaker:
Jacob Dewees RDCS,
Clinical Luminary Leader
GE HealthCare, CVUS

2:30 – 3:30 p.m.
4369.  Myocardial Work – A New Way of Looking at Heart Function

• Be introduced to the concepts of myocardial work
• Understand how to achieve the measurement of Myocardial Work utilizing Strain AFI on Echocardiography
• Discover how Myocardial Work can be utilized in different disease states and the corresponding results
• Get Hands-on learning using EchoPac on real cases

Speaker: 
Salima Qamruddin, MD
Director Echo Quality and Research and Director, Women's Cardiovascular Clinic
Ochsner Heart and Vascular Institute
New Orleans LA

4 – 4:45 p.m.
4370. Optimizing 4D Images and Quantification of LV and LA Volumes

• Learn how to optimize 4D Volumes
• Discover how to quantify 4D Volumes of the Left Ventricle and Left Atrium using one tool 4D Auto LVQ
• Learn how to navigate a 4D Volume
• Get hands-on learning using 4D images on EchoPac laptops

Monday, March 30

9:30 – 10:30 a.m.
4362. 4D Valves: Cropping and Multiplanar Reconstruction of 4D TEE

• Learn how to manipulate 4D TEE echo images
• Review Valve orientations needed for Structural Valve Procedures and surrounding anatomical landmarks on 4D TEE
• Discover the methods of Multi-Planar Reconstruction (Flexi-Slice)
• Learn how MPRs Flexi-Slice can help with procedural guidance and measurements
• Practice manipulating 4D images from real cases on EchoPac laptops

Speaker: 
Renuka Jain, MD, FACC
Director of Echocardiography,
Aurora St. Luke's Medical Center
Milwaukee, WI

11 a.m. – Noon
4371. Artificial Intelligence in Echo: Using AI and Vivid Technologies to Improve Echo Lab Workflow

• Understand the types of artificially intelligent tools that are available in echo
  • View recognition
  • Measurements – Cardiac Auto Doppler, Easy AFI, Auto EF
  • Image Acquisition Guidance with Caption
  • Offline analysis and reporting with Echo Pilot on View Point
• Discover other technologies that can help make your Echo Lab more efficient
• Review images on EchoPAC and how to apply AI

Speaker:
Jacob Dewees RDCS
Clinical Luminary Leader
GE HealthCare, CVUS

Room 223
Sponsored by Pfizer

Saturday, March 28

2 – 3 p.m.
4380. Getting ATTR-CM Nuclear Scintigraphy Right: Practical Guidance For Clinical Practice
Cardiac nuclear scintigraphy is central to the noninvasive diagnosis of ATTR‑CM, yet variability in acquisition and interpretation can affect diagnostic confidence. This session provides practical guidance on appropriate clinical suspicion, optimization of SPECT‑based image acquisition, and accurate interpretation of PYP/HMDP studies. Using illustrative cases, faculty will highlight key principles, common pitfalls, and best practices to support appropriate use of nuclear imaging.

3:15 – 4:15 p.m. 4382. Optimizing ATTR-CM Care: Interpreting Change Over Time
Transthyretin amyloid cardiomyopathy (ATTR‑CM) is a progressive disease in which clinical, imaging, and laboratory findings may evolve at different rates. This session focuses on optimizing longitudinal patient care using a guidance‑informed approach to interpreting change over time. Through case-based discussion, faculty will explore how to navigate disease progression, emphasizing thoughtful assessment of symptoms, functional status, imaging, and biomarkers within the broader clinical context.

Sunday, March 29

10:45 – 11:45 a.m.
4381. Optimizing ATTR-CM Care: Interpreting Change Over Time
Transthyretin amyloid cardiomyopathy (ATTR‑CM) is a progressive disease in which clinical, imaging, and laboratory findings may evolve at different rates. This session focuses on optimizing longitudinal patient care using a guidance‑informed approach to interpreting change over time. Through case-based discussion, faculty will explore how to navigate disease progression, emphasizing thoughtful assessment of symptoms, functional status, imaging, and biomarkers within the broader clinical context.

Room 227
Sponsored by Boston Scientific

Saturday, March 28

10 a.m. – 11 a.m.
4340. Calcium IVUS Interpretation Laptop Session
Want to use your Boston IVUS like a pro? Join one of our laptop sessions where we'll walk you through the AVVIGO+ interface, share workflow tips, and use case examples to sharpen your IVUS interpretation skills. Seats are limited and will be assigned on a first-come, first-served basis.

12:30 – 1:30 p.m.
4341. Breaking NEWS in PE: HI-PEITHO Clinical Trial Results – Implications to Patient Care
In this session, a multidisciplinary panel of leaders in pulmonary embolism will examine the results and real-world impact of the recent HI-PEITHO data release. This multi-country, multicenter landmark RCT was designed and conducted in partnership between society, industry, and academia to achieve impactful results through robust study design and large patient population to address to answer the biggest questions in pulmonary embolism care today.

Speakers:

Michael R. Jaff, DO, FACP, FACC (Moderator)

Erik Klok, MD, PhD

Stavros Konstantinides, MD, FESC

Peter Monteleone, MD, FACC, FSCAI

Soophia Naydenov, MD, FCCP

Gregory Piazza, MD, MS

Kenneth Rosenfield, MD, MSC, MHCDS, MSCAI

Andrew Sharp, MBChB, MD, FRCP

Michael Young, MD, FSCAI, RPVI

2:30 – 3:30 p.m.
4342. Advancing PCI With the AGENT™ Drug Coated Balloon: Biology, Data, and Real-World Strategy
This symposium will provide a comprehensive review of the scientific rationale and expanding clinical evidence supporting the AGENT™ drug‑coated balloon (DCB) in contemporary coronary intervention. Faculty will examine the pharmacologic mechanism of DCB therapy, present key outcomes from recent clinical data releases, and evaluate their implications within today's evolving PCI landscape. Through focused, case-based discussions, the session will translate the emerging clinical evidence into practical, lesion-specific decision-making pathways to optimize outcomes and preserve future treatment options.

Speakers:

Pratik Sandesara, MD
Interventional Cardiologist
Complex Coronary & CTO Interventions
Assistant Professor of Medicine
Division of Cardiology
Director
Interventional Cardiovascular Research and Clinical Trials
Emory Heart and Vascular
Emory University School of Medicine

Wayne Batchelor, MD
President
Medicine Service Line, Inova Health System
Immediate-Past Chair
ACC Interventional Cardiology Section
Vice-Chair
NCDR STS/ACC TVE Registry
Professor of Medicine
Duke University School of Medicine

Kate Kearney, MD
Medical Director of the Cardiac Cath Lab
UWMC Montlake
Associate Professor
Division of Cardiology
UW School of Medicine
University of Washington Medical Center

4 – 5 p.m.
4343. LUX-Dx Hands-On Training Session
In this 60 minute session, get hands-on with Boston Scientific's LUX-Dx II+ ICM insertion workflow. Training will include a short presentation and hands-on insertion practice.

Sunday, March 29

9:30 – 11 a.m.
4344. ROTAPRO Virtual Reality Case Experience
Step into the lab and experience a previously recorded live case in virtual reality to learn from operators firsthand. Cases are 30 mins and will begin at 9:30 a.m., 10 a.m., and 10:30 a.m.

11:45 a.m. – 1 p.m.
4345. Renal Denervation in Hypertension Care: Evidence, Innovation, and What's Next
This symposium will examine hypertension as a persistent global health challenge and the ongoing need for novel treatment approaches. The session will review the current renal denervation evidence base, highlighting how clinical trial data have shaped the therapy's evolution. Attendees will learn about emerging ultrasound-based renal denervation techniques, including early experience with TIVUS, and explore how upcoming evidence from the THRIVE trial may further define the role of RDN in clinical practice. The program will provide a forward-looking perspective on how innovation and evidence may reshape hypertension management strategies.

Speakers:

Andrew SP Sharp, MBChB, MD
Senior Medical Director
Boston Scientific
Adjunct Professor of Cardiovascular Medicine
University College Dublin
Dublin, Ireland

Michael Bloch, MD, FAHA, FASH, FNLA, FSVM, FACP
Clinical Associate Professor University of Nevada School of Medicine
Medical Director
Renown Vascular Care
Renown Institute for Heart and Vascular Health
President
Blue Spruce Medical Consultants, PLLC

David Kandzari, MD, FACC, MSCAI
Chief
Piedmont Heart Institute and Cardiovascular Services
Director
Interventional Cardiology
Piedmont Heart Institute
Atlanta, GA

Florian Rader, MD, MSc
Medical Director
Hypertension Center of Excellence
Director
Clinic for Hypertrophic Cardiomyopathy
Interm Director
Non-invasive Laboratory
Smidt Heart Institute
Department of Cardiology
Cedars-Sinai Medical Center

1:30 – 2:30 p.m.
4346. ISR IVUS Image Interpretation Laptop Session
Want to use your Boston IVUS like a pro? Join one of our laptop sessions where we'll walk you through the AVVIGO+ interface, share workflow tips, and use case examples to sharpen your IVUS interpretation skills. Seats are limited and will be assigned on a first-come, first-served basis.

4 – 5 p.m.
4347. Elevating AFib Care in Resource-Limited Environments
With a special focus on veteran patients, this program is for electrophysiologists, interventional cardiologists, referring clinicians, and AFib program leaders committed to scalable, system-level improvement even in resource-constrained environments. This compelling program guided by the Four Pillars of atrial fibrillation (AFib) management showcases how evidence-based, fully integrated AFib solutions can unlock greater access, streamline care delivery, and elevate outcomes for patients. Beginning with a candid "State of the State" on AFib care, Dr. Creighton Don will examine the burden of disease and where innovation can meaningfully elevate care delivery. Dr. Brad Sutton will bring the evidence to life, translating data insights into practical, real-world strategies that empower confident, consistent, data-driven decisions. An expert panel of VA physicians will demonstrate how scalable program design, state-of-the-art ablation and LAAC technologies, and coordinated long-term management can work together to build a seamless, end-to-end AF pathway.

Speakers:

Creighton W. Don, MD MPH

Brad Sutton, MD, CMO
AF Solutions, Boston Scientific

Monday, March 30

9 a.m. – Noon
4348. LUX-Dx Hands-On Training Session